←   Back to Insights

Preeclampsia Study

05/08/2025

Preeclampsia is a multi-system vascular disease which affects 2-5% of pregnancies. It is also a risk factor for the development of cardiovascular disease later in life and a number of functional and structural cardiac changes have been found in this population of patients.

This study aims to intimately link the maternal immunological and vascular components of cardiac dysfunction in women preeclampsia. The investigators hypothesise that in preeclampsia activated neutrophils may affect maternal immune system thus leading to myocardial injury and altered cardiac function. The study intends to identify the mechanisms by which the maternal immune system (focusing on neutrophil and T-cell subsets) affects cardiac function in women with preeclampsia.

Cardiac function will be evaluated using cardiovascular magnetic resonance, echocardiography and cardiac markers in the blood.

More details about the study: Cardiac and Immune Cell Function in Preeclampsia

Recent Insights
  • 30/07/2025

    CardioInspect Featured in “Prévention et réadapation cardiovasculaire” Book

  • 01/07/2025

    SAFIR Project: A Multicenter Initiative Advancing AI-Driven Cardiovascular Risk Stratification

  • 01/06/2025

    Imageens in the Spotlight at the Euro-Asian Bridge Society 2025 Congress